[Trial Data] TRIUMPH timeline — what we actually know vs what gets repeated
Trying to settle this properly because the thread from last year went in circles. The claim: glucagon matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 20 months without either producing anything. What would actually settle it is 19 people measuring the same…
Flair changed to match the content. Read the sidebar before posting next time and we are square.
This is correct. Triple agonism is genuinely different.
Not convinced. The evidence does not support that reading.
Respectfully this is a sample of one presented as a finding.
research use only, handling and analysis, not protocols
research use only, handling and analysis, not protocols
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
This is correct. Triple agonism is genuinely different.
heart rate and dose escalation need actual measurements, not impressions
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
This is correct. Triple agonism is genuinely different.
the glucagon component changes the side effect profile, not just the efficacy
research use only, handling and analysis, not protocols
Are you quoting phase 2 or is there phase 3 data now?
nobody should be giving this to anyone without extensive monitoring
Not to be pedantic but retatrutide and dose escalation are being used interchangeably and they are not interchangeable in real life.
phase 2 numbers are not maintenance numbers, cite the trial